ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,396Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 609

$823K Total Retail Price of All Prescriptions

Rank: 43 out of 609

344 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SYMBICORT 326 199 1 139
SPIRIVA 306 166 2 43
AMLODIPINE BESYLATE 271 217 3 2
FUROSEMIDE 222 154 4 4
OMEPRAZOLE 222 157 4 3
PROAIR HFA 214 79 6 57
SIMVASTATIN 213 170 7 1
DIOVAN HCT 191 116 8 31
METOPROLOL TARTRATE 187 164 9 9
METFORMIN HCL 173 119 10 10
SINGULAIR 170 102 11 78
CLOPIDOGREL 154 123 12 17
ZOLPIDEM TARTRATE 153 95 13 18
AMOX TR-POTASSIUM CLAVULANATE 149 92 14 249
WARFARIN SODIUM 148 124 15 8
FLOVENT HFA 138 54 16 312
DALIRESP 136 82 17 358
ATORVASTATIN CALCIUM 130 106 18 6
DIOVAN 129 100 19 15
BYSTOLIC 119 76 20 71
GLIMEPIRIDE 118 101 21 53
OXYCODONE-ACETAMINOPHEN 110 92 S2 22 44
PLAVIX 110 83 22 25
CRESTOR 109 93 24 16
DONEPEZIL HCL 104 95 25 22
ENDOCET 94 52 S2 26 45
JANUVIA 92 76 27 34
PREDNISONE 90 55 28 26
MONTELUKAST SODIUM 88 64 29 152
ACETAMINOPHEN-CODEINE 86 72 S3 30 136
LEVETIRACETAM 85 65 31 70
BENICAR HCT 84 56 32 232
PANTOPRAZOLE SODIUM 78 58 33 29
IBUPROFEN 74 41 34 103
ADVAIR DISKUS 73 28 35 28
CYCLOBENZAPRINE HCL 73 34 R 35 95
NEXIUM 72 52 37 13
IPRATROPIUM-ALBUTEROL 71 69 38 173
FLUTICASONE PROPIONATE 71 37 38 52
ONGLYZA 70 62 40 178
HYDROCORTISONE 70 46 40 297
LEVEMIR 70 52 40 280
HUMALOG 70 55 40 117
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 44 44 94
CYMBALTA 67 23 45 76
ALBUTEROL SULFATE 65 65 46 201
DIGOXIN 65 65 46 33
FAMOTIDINE 65 48 46 50
CARVEDILOL 64 56 49 14
SANTYL 62 62 50 186
ESCITALOPRAM OXALATE 60 33 51 91
HYDROCHLOROTHIAZIDE 60 48 51 20
LEVOTHYROXINE SODIUM 58 58 53 7
ATELVIA 54 53 54 188
PROMETHAZINE HCL 54 26 R 54 311
RAMIPRIL 51 38 56 46
LEVOFLOXACIN 51 28 56 127
LYRICA 51 34 56 90
NAMENDA 51 51 56 36
CELEBREX 51 35 56 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.